US firm, backed by Fosun and Tencent, expands research base in China as it develops an AI-powered drug-discovery tool Biotech ...

Zimislecel is an allogeneic stem cell-derived islet cell therapy that could eliminate the need for insulin in those who have ...

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) ('Tonix” or the 'Company”), a fully-integrated commercial stage biotechnology company, today announced it has entered into a securities purchase ...

For Section 337 investigations before the U.S. International Trade Commission (ITC), 2025 was a year of contrasts.

Exploring clinical development plan options including a controlled human infection model (CHIM) and a Phase 2/3 adaptive ...

Life science marketing is changing, and with it our need for personalised engagement strategies. While omnichannel marketing ...